These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38563881)
1. The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patients. Nielsen AW; Hansen IT; Nielsen BD; Kjær SG; Blegvad-Nissen J; Rewers K; Sørensen CM; Hauge EM; Gormsen LC; Keller KK Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2614-2624. PubMed ID: 38563881 [TBL] [Abstract][Full Text] [Related]
2. Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica. van der Geest KSM; van Sleen Y; Nienhuis P; Sandovici M; Westerdijk N; Glaudemans AWJM; Brouwer E; Slart RHJA Rheumatology (Oxford); 2022 Mar; 61(3):1072-1082. PubMed ID: 34117743 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248 [TBL] [Abstract][Full Text] [Related]
5. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol. Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131 [TBL] [Abstract][Full Text] [Related]
6. PET-CT findings in patients with polymyalgia rheumatica without symptoms of cranial ischaemia. Lund-Petersen A; Voss A; Laustrup H Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975885 [TBL] [Abstract][Full Text] [Related]
7. Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment. Palard-Novello X; Querellou S; Gouillou M; Saraux A; Marhadour T; Garrigues F; Abgral R; Salaün PY; Devauchelle-Pensec V Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):773-9. PubMed ID: 26753600 [TBL] [Abstract][Full Text] [Related]
8. Use of Pean de Ponfilly-Sotier M; Besson FL; Gomez L; Ottaviani S; Dieudé P; Pavy S; Mariette X; Seror R; Nocturne G Joint Bone Spine; 2022 May; 89(3):105325. PubMed ID: 34915108 [TBL] [Abstract][Full Text] [Related]
9. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429 [TBL] [Abstract][Full Text] [Related]
11. Muscle involvement on 18F-FDG PET-CT in polymyalgia rheumatica. A controlled retrospective study of 101 patients. Wendling D; Sondag M; Giraud N; Chouk M; Boulahdour H; Prati C; Verhoeven F Joint Bone Spine; 2020 May; 87(3):225-228. PubMed ID: 32007650 [TBL] [Abstract][Full Text] [Related]
12. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR? Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410 [TBL] [Abstract][Full Text] [Related]
13. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Owen CE; Poon AMT; Yang V; McMaster C; Lee ST; Liew DFL; Leung JL; Scott AM; Buchanan RRC Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2461-2468. PubMed ID: 32090280 [TBL] [Abstract][Full Text] [Related]
14. The usefulness of 18F-FDG-PET/CT in detecting musculoskeletal and vascular involvement in patients with polymyalgia rheumatica receiving glucocorticoids. Serrano-Combarro A; Prieto-Peña D; Martínez-Rodríguez I; Martínez-Amador N; Loricera J; Blanco R Eur J Intern Med; 2024 Jun; 124():78-83. PubMed ID: 38302404 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis. Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697 [TBL] [Abstract][Full Text] [Related]
16. Diagnosing polymyalgia rheumatica on Yuge S; Nakatani K; Yoshino K; Koyama T Ann Nucl Med; 2018 Oct; 32(8):573-577. PubMed ID: 29948622 [TBL] [Abstract][Full Text] [Related]
17. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Owen CE; Poon AMT; Lee ST; Yap LP; Zwar RB; McMenamin CM; Lam SKL; Liew DFL; Pathmaraj K; Kemp A; Scott AM; Buchanan RRC Rheumatology (Oxford); 2018 Feb; 57(2):345-353. PubMed ID: 29121248 [TBL] [Abstract][Full Text] [Related]
18. Early onset polymyalgia rheumatica: two rare cases under age of 50. Park J; Sung DH Skeletal Radiol; 2017 Jun; 46(6):837-840. PubMed ID: 28324118 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis. Ikuma D; Sawa N; Yamanouchi M; Oba Y; Mizuno H; Suwabe T; Hoshino J; Ubara Y Mod Rheumatol; 2024 Mar; 34(3):474-478. PubMed ID: 37279960 [TBL] [Abstract][Full Text] [Related]
20. Role of Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]